Mackenzie Financial Corp Iridex Corp Transaction History

Mackenzie Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.0 - $2.63 $4,800 - $6,312	2,400 Added 12.61%	21,438 $43,000
Q3 2022 Oct 07, 2022	BUY	$2.41 - $3.41 $6,208 - $8,784	2,576 Added 15.65%	19,038 $46,000
Q2 2022 Aug 10, 2022	BUY	$2.48 - $4.66 $10,956 - $20,587	4,418 Added 36.68%	16,462 $42,000
Q1 2022 May 13, 2022	BUY	$3.99 - $6.42 $48,055 - $77,322	12,044 New	12,044 $56,000

3.25M

500

61.3K

Ticker IRIX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 15,985,600
Market Cap $22.2M
Description
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.